NCT00312104 Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00294723 To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c Status TERMINATED Phase PHASE3
NCT00283751 Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00283218 A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. Status COMPLETED Phase NA
NCT00282698 Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients Status COMPLETED Phase PHASE3
NCT00282594 The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit Status COMPLETED Phase NA
NCT00282451 Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00280046 Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00274274 Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00267683 Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT00264901 Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00262249 Effect of Growth Hormone in Children With Growth Hormone Deficiency Status COMPLETED Phase PHASE3
NCT00254514 Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures Status COMPLETED Phase PHASE2
NCT00187993 Growth Hormone Treatment of Young Growth Hormone-Deficient Adults Status UNKNOWN Phase N/A
NCT00184795 Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations Status COMPLETED Phase PHASE3
NCT00184769 Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. Status COMPLETED Phase PHASE4